The Food and Drug Administration’s (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respiratory viral season. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on Thursday to discuss whether COVID-19 vaccines should target the NB.1.8.1…
Politics
·
FDA advisers to weigh updated COVID vaccine targeting XFG subvariant
CN
CitrixNews Staff
Originally reported by The Hill
Related Articles
Politics
Runoff Polls in Texas Senate Contest Have Favored Ken Paxton
Mr. Paxton, a Texas Senate candidate, has led Senator John Cornyn in all but one independent poll in the Republican prim...
CitrixNews Staff
·
42 minutes ago
Politics
Trump Administration to Send Americans Exposed to Ebola to Kenya
In past outbreaks, Americans exposed to the virus were sent home to be treated in state-of-the-art facilities. The Trump...
CitrixNews Staff
·
1 hour ago
Politics
The Memo: Trump and allies seek to spin Iran deal amid hazy details
A fierce battle is underway to shape public perceptions of a deal to end the war in Iran — even though no such agreement...
CitrixNews Staff
·
1 hour ago
Politics
DOE eyes using plutonium in nuclear fuel
{beacon} Energy & Environment Energy & Environment   The Big Story  DOE eyes using plutonium for nu...
CitrixNews Staff
·
1 hour ago